regulator pain drug
drug regulators decide recommend painkillers linked heart stroke
drug fda advisory panel verdict hearing painkillers inhibitors brand names celebrex vioxx vioxx withdrawn shops merck selling fda approval fda decide patients justify risks
putting vioxx shelves profits merck easier battles injured drug
merck voluntarily stopped vioxx caused earnings slide merck shares tumbled millions dollars cover litigation alarm bells rung note approve heart stroke doubled patients drug inhibitors developed drug merck pfizer users fewer stomach painkillers
pfizer selling celebrex bextra investigations harmful heart merck reintroduction vioxx caught surprise merck kim withdrew vioxx knowing alternative therapies changed light cardiovascular observed approve vioxx unique class drugs marketed kim explained
graham fda drug safety advisory panel inhibitors calculations senate graham vioxx linked deaths stem handling vioxx fda oversee safety drugs regulators patients heart disease stroke inhibitors medicines doctors cautious drugs patients factors heart disease
